Ajit Mishra Bullish on MCX, Apollo Hospitals; Bearish on TCS

Ajit Mishra Highlights Investment Opportunities in MCX and Apollo Hospitals, Cautions on TCS

Ajit Mishra’s latest insights reveal a bullish outlook for MCX and Apollo Hospitals, while suggesting caution for TCS amid ongoing market fluctuations.

Market Overview: Recovery Amidst Volatility

On Wednesday, Indian equity markets extended their recovery, with the Nifty and Sensex gaining approximately 0.5% and 0.4%, respectively. This uptick was influenced by positive global cues, particularly as Brent crude oil prices remained below $100 per barrel, alleviating some inflationary pressures. However, the market’s resilience is tempered by persistent foreign institutional investor (FII) selling, which has seen outflows exceeding ₹3,810 crore in the previous session alone. This trend has raised concerns about the sustainability of the current market rebound.

Despite the challenges, domestic institutional investors (DIIs) have been active buyers, providing some support to the market. Technically, the Nifty is facing resistance at the 23,600 level, while a drop below 23,300 could signal a reversal in the current recovery trend. The banking sector’s performance will be crucial in determining whether the market can maintain its upward trajectory.

Bullish on Apollo Hospitals: A Strong Uptrend

Mishra is optimistic about Apollo Hospitals Enterprise Limited, recommending it as a buy with a target price of ₹9,750 and a stop-loss at ₹8,720. The stock has shown resilience in the healthcare sector, maintaining a strong uptrend and trading above its key moving averages. Following a period of consolidation, Apollo Hospitals has broken out from its previous range, indicating a continuation of its bullish momentum. Investors are encouraged to participate in this upward movement, capitalizing on the stock’s potential for further gains.

MCX: Positioned for Growth

Mishra also highlights the Multi Commodity Exchange of India Limited (MCX) as a buy, with a target price of ₹3,630 and a stop-loss at ₹3,245. The stock has demonstrated a steady uptrend and recently recovered from its 200-day exponential moving average (EMA). Following a brief consolidation, MCX has formed a bullish trend-continuation setup, suggesting that it is well-positioned for further gains. The stock’s relative strength compared to its peers adds to its attractiveness, making it a compelling opportunity for investors.

Caution on TCS: Bearish Outlook

In contrast, Mishra adopts a bearish stance on Tata Consultancy Services Limited (TCS), recommending a sell position with a target of ₹1,980 and a stop-loss at ₹2,130. The stock’s recent recovery has faced significant resistance, and it has slipped below critical support levels, forming a bearish trend-continuation pattern. This setup indicates potential further weakness, prompting traders to consider shorting opportunities in the stock.

Key Highlights

• Apollo Hospitals is recommended as a buy with a target of ₹9,750.
• MCX shows bullish potential with a target of ₹3,630.
• TCS is advised to be sold, targeting ₹1,980.
• Market recovery is supported by positive global cues and DII buying.
• FII selling remains a concern, impacting market sustainability.

Investor Note: The current market environment calls for a selective investment strategy, particularly in sectors showing resilience like healthcare and commodities, while exercising caution in IT stocks like TCS that may face headwinds.